These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2731989)

  • 21. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1.
    Rubinchik E; Chow AW
    Vaccine; 2000 Apr; 18(21):2312-20. PubMed ID: 10717352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1.
    Shimonkevitz R; Boen E; Malmstrom S; Brown E; Hurley JM; Kotzin BL; Matsumura M
    Infect Immun; 1996 Apr; 64(4):1133-9. PubMed ID: 8606069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
    Hofer MF; Lester MR; Schlievert PM; Leung DY
    Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH; Russell JK; Johnson HM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.
    Poindexter NJ; Schlievert PM
    J Infect Dis; 1985 Jan; 151(1):65-72. PubMed ID: 3871225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
    Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
    J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].
    Takei S; Arora YK; Walker SM
    J Clin Invest; 1993 Feb; 91(2):602-7. PubMed ID: 8432865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
    Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
    Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Demonstration of the toxic shock syndrome toxin (TSST-1) in S. aureus using a modified ELISA procedure and antibody demonstration in gamma globulin preparations].
    Fey H; Pfister H; Boerlin P
    Schweiz Med Wochenschr; 1987 May; 117(19):712-5. PubMed ID: 2438764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach.
    Pontzer CH; Russell JK; Johnson HM
    J Immunol; 1989 Jul; 143(1):280-4. PubMed ID: 2499630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function analysis of toxic shock syndrome toxin 1.
    Edwin C
    Rev Infect Dis; 1989; 11 Suppl 1():S137-9. PubMed ID: 2928629
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
    Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
    Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
    Bavari S; Ulrich RG; LeClaire RD
    J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1.
    Scott DF; Best GK; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
    Rev Infect Dis; 1989; 11 Suppl 1():S214-7; discussion S217-8. PubMed ID: 2928638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
    Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
    Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
    Fukushima H; Hirano T; Oka K
    Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1.
    Wells DE; Reeves MW; McKinney RM; Graves LM; Olsvik O; Bergan T; Feeley JC
    J Clin Microbiol; 1987 Mar; 25(3):516-21. PubMed ID: 3106406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.